Objective miR-22 is highly active in breast cancer, especially in the luminal B and HER2 subtypes. However, the detailed potential of the use of target genes fo
Objective The relationship between the expression of kinesin family member 15 (KIF15) and clinicopathological features in breast cancer (BC) remains controversi